Leerink Swann Downgrades Carbylan Therapeutics Inc to Market Perform
Brokerage firm Leerink Swann Downgrades its rating on Carbylan Therapeutics Inc(NASDAQ:CBYL). The shares have been rated Market Perform. Previously, the analysts had a Outperform rating on the shares....
View ArticleBarclays Maintains ENSCO PLC to Equalweight with Price Target $9.00
Brokerage firm Barclays Maintains its rating on ENSCO PLC(NYSE:ESV). In a research note issued to the investors, the brokerage major Lowers a price-target of $9.00 per share. The shares have been rated...
View ArticleRBC Capital Initiates Coverage on Kite Pharma Inc to Outperform
RBC Capital Initiates Coverage on Kite Pharma Inc(NASDAQ:KITE). The shares have been rated Outperform. The rating by RBC Capital was issued on Feb 2, 2016. In a different note, SunTrust Robinson...
View ArticleZacks Rating on Rockwell Collins, Inc. (NYSE:COL)
Research firm Zacks Investment Research has rated Rockwell Collins, Inc. (NYSE:COL) and has ranked it at 2, indicating that for the short term the shares are a buy. 12 Wall Street analysts have given...
View Article